Alps Advisors Inc Aveo Pharmaceuticals, Inc. Transaction History

Alps Advisors Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$3.51 - $6.67 $123,990 - $235,617	-35,325 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$3.15 - $6.01 $14,017 - $26,744	-4,450 Reduced 11.19%	35,325 $197,000
Q4 2021 Feb 09, 2022	SELL	$4.69 - $7.4 $11,016 - $17,382	-2,349 Reduced 5.58%	39,775 $187,000
Q3 2021 Nov 15, 2021	SELL	$5.12 - $6.89 $16,025 - $21,565	-3,130 Reduced 6.92%	42,124 $260,000
Q2 2021 Aug 11, 2021	BUY	$6.21 - $7.45 $281,027 - $337,142	45,254 New	45,254 $298,000

Ticker AVEO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,676,000
Description
AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the ...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.